Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems - ScienceDirect

Inhaled Medicines: Past, Present, and Future

The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy - The Lancet Respiratory Medicine

COVID-19: A promising cure for the global panic - ScienceDirect

Inhaled RNA Therapy: From Promise to Reality: Trends in Pharmacological Sciences

Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage - ScienceDirect

Targeted pulmonary drug delivery in coronavirus disease (COVID-19) therapy: A patient-specific in silico study based on magnetic nanoparticles-coated microcarriers adhesion - ScienceDirect

Localized delivery of nanomedicine and antibodies for combating COVID-19 - ScienceDirect

Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines: Trends in Molecular Medicine

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study - The Lancet Respiratory Medicine

Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine